Glycogen storage disease type III, abbreviated GSD III, is an autosomal recessive metabolic disorder and an inborn error of carbohydrate metabolism, characterised by a deficiency of the glycogen debranching enzyme. It is also called Cori disease, after the 1947 Nobel laureates Carl and Gerty Cori, Forbes disease, after the American physician Gilbert Burnett Forbes who further described its features, and limit dextrinosis, after the limit dextrin-like structures that accumulate in the cytosol. Because the debrancher enzyme, amylo-1,6-glucosidase, is deficient, abnormal glycogen is deposited in the liver, the muscles and in some cases the heart. This entry follows the lead of the cited English Wikipedia article and is not medical advice.
Facts
Classification
ICD-10 ChapterIV: Endocrine, Nutritional and Metabolic Diseases 1 Communicable or Non-communicable Causative Agent
Causative Agent (category) Sources
1. Glycogen storage disease type III (Wikipedia)
Lead
an autosomal recessive metabolic disorder and inborn error of metabolism
lead sentence 1
Glycogen storage disease type III (GSD III) is an autosomal recessive metabolic disorder and inborn error of metabolism (specifically of carbohydrates) characterized by a deficiency in glycogen debranching enzymes.
Lead: disease category
Glycogen storage disease type III (GSD III) is an autosomal recessive metabolic disorder and inborn error of metabolism (specifically of carbohydrates) characterized by a deficiency in glycogen debranching enzymes.
View the SourceReader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.